Expand PLSE Menu
PLSE MENU

PLSE Latest Press Releases

-- January 9, 2026 --

Pulse Biosciences, Inc. Appoints Maria Sainz to its Board of Directors Business Wire 7:00 AM

-- January 6, 2026 --

Pulse Biosciences Selected to Present Late-Breaking Data from the nPulse Cardiac Catheter Study at the AF Symposium Business Wire 7:00 AM

-- December 29, 2025 --

Pulse Biosciences to Present at the 44th Annual J.P. Morgan Healthcare Conference Business Wire 4:05 PM

-- December 19, 2025 --

Pulse Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Business Wire 4:05 PM

-- December 18, 2025 --

Pulse Biosciences Announces FDA IDE Approval to Initiate its nPulse Cardiac Catheter Ablation System Study for the Treatment of Atrial Fibrillation Business Wire 7:00 AM

-- December 9, 2025 --

Pulse Biosciences, Inc. Announces Initiation of Research Collaboration for the Treatment of Benign and Malignant Thyroid Tumors with nPulse Technology Business Wire 7:00 AM

-- November 21, 2025 --

Pulse Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Business Wire 4:05 PM

-- November 6, 2025 --

Pulse Biosciences, Inc. Announces Participation in Upcoming Investor Conferences Business Wire 4:05 PM

-- November 5, 2025 --

Pulse Biosciences Reports Business Updates and Third Quarter 2025 Financial Results Business Wire 4:05 PM

-- October 24, 2025 --

Pulse Biosciences Announces First Enrollment in the NANOCLAMP AF Study Business Wire 7:00 AM

-- October 22, 2025 --

Pulse Biosciences Schedules Third Quarter 2025 Business Updates and Financial Results Conference Call for November 5, 2025 Business Wire 4:05 PM

-- October 16, 2025 --

Pulse Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Business Wire 7:00 AM

-- October 10, 2025 --

Pulse Biosciences Announces Presentation of Late-Breaking Data From the nPulse Cardiac Surgical System First-in-Human Feasibility Study at the 39th European Association for Cardio-Thoracic Surgery Annual Meeting Business Wire 7:00 AM

-- October 7, 2025 --

Pulse Biosciences Announces Clinical Data Highlighting its nPulse Cardiac Surgical System to be Presented at the 39th European Association for Cardio-Thoracic Surgery Annual Meeting Business Wire 7:00 AM

-- September 17, 2025 --

Pulse Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Business Wire 7:00 AM

-- September 10, 2025 --

Pulse Biosciences' nPulse Technology to be Featured at the American Thyroid Association 2025 Annual Meeting Business Wire 7:00 AM

-- September 8, 2025 --

Pulse Biosciences Announces FDA IDE Approval to Initiate its nsPFA Cardiac Surgery System Study for the Treatment of Atrial Fibrillation Business Wire 7:00 AM

-- September 4, 2025 --

Pulse Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Business Wire 7:00 AM

-- September 2, 2025 --

Pulse Biosciences Announces First Successful Procedures in PRECISE Benign Thyroid Nodule (BTN) Study Business Wire 7:00 AM

-- August 31, 2025 --

Pulse Biosciences' Earnings Call: Clinical Gains and Financial Hurdles TipRanks 9:07 PM

-- August 26, 2025 --

Pulse Biosciences Announces Publication of First-In-Human Data for Treatment of Benign Thyroid Nodules in the Journal Thyroid Business Wire 7:00 AM
Market Data Delayed 15 Minutes